Clinical Trials

138 enrolled

Advanced/Metastatic Solid Tumors

NCT07475559 2026-03-16

JSKN016HC in Patients With Advanced or Metastatic Solid Malignant Tumors

42 enrolled

Advanced Solid Tumor Malignancies

NCT07469774 2026-03-13

BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

111 enrolled

Locally Advanced or Metastatic Solid Tumors

NCT07467629 2026-03-12

QLS5212 for Participants With Advanced Solid Tumors

100 enrolled

Solid Tumor Cancer

NCT07459998 2026-03-10

SKB103 for Injection in Advanced Solid Tumors

277 enrolled

Advanced Solid Tumors

NCT07460375 2026-03-10

A Study to Evaluate Claudin 18.2-Directed ADC LCB02A in Advanced Solid Tumors

191 enrolled

Advanced Solid Tumors

NCT07462442 2026-03-10

Study of QLS5308 in Patients With Advanced Solid Tumors

192 enrolled

Metastatic Solid Tumors

NCT07455734 2026-03-06

Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors

533 enrolled

Advanced Solid Tumor Cancer

NCT07362888 2026-03-03

First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors

180 enrolled

Solid Tumors (Phase 1)

NCT07446855 2026-03-03

PARTHENON

180 enrolled

Solid Tumours

NCT07346846 2026-03-02

A Study of BGM-2121 in Patients With Advanced Solid Tumors

35 enrolled

Advanced Solid Tumors

NCT07176975 2026-02-27

A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers

46 enrolled

Phase 3 Not yet recruiting

Solid Tumors

NCT07412613 2026-02-27

Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer

386 enrolled

GastrointestinalOther solid neoplasm

Resectable Colon Cancer

NCT07413328 2026-02-27

HWS116 Monotherapy in Patients With Advanced Solid Tumors

56 enrolled

Advanced Solid Tumors

NCT07436728 2026-02-27

A Study of TAK-505 in Adults With Solid Tumors

151 enrolled

Malignant Solid Tumors

NCT07434609 2026-02-25

Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors

150 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Advanced Solid Tumor (Phase 1)

NCT07412665 2026-02-17

A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.

10 enrolled

Advanced Solid Tumors

NCT07414836 2026-02-17

A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors

84 enrolled

Phase 2 Not yet recruiting

Advanced Solid Tumor

NCT07415031 2026-02-17

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

170 enrolled

Solid Tumors

NCT07408258 2026-02-13

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors

20 enrolled

Advanced Solid Tumor

NCT07407504 2026-02-12

GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated, Locally Advanced or Metastatic Solid Tumors.

186 enrolled

Phase 2 Not yet recruiting

Locally Advanced or Metastatic Solid Tumors With PIK3CA-mutated

NCT07390383 2026-02-09

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

110 enrolled

Advanced Solid Tumour

NCT07395258 2026-02-09

A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

60 enrolled

Solid Tumors

NCT07396584 2026-02-09

A Phase I/Ⅱa Study of HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor

186 enrolled

Solid Tumors, Adult

NCT07391644 2026-02-06

A Study of JSKN027 in Patients With Advanced Solid Tumors

250 enrolled

Advanced Malignant Solid Tumor

NCT07380334 2026-02-02

A Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-1049 in Patients With Advanced Solid Tumors

200 enrolled

Advanced Solid Tumor

NCT07380386 2026-02-02

SKB105 for Injection in Advanced Solid Tumors

256 enrolled

Phase 2 Not yet recruiting

Advanced Solid Tumors

NCT07359820 2026-01-22

ReFocus202

FGFR2 Gene Fusion/Rearrangement

NCT07348653 2026-01-21

A Study of MG2512 Injection in Participants With Advanced Solid Tumors

116 enrolled

Advanced Solid Tumor

NCT07294872 2026-01-16

A Study of TIL in Advanced Solid Tumors (CZ)

Solid Tumor, Adult

NCT07345637 2026-01-16

FXS887-I101

14 enrolled

Solid Tumor Refractory to Conventional Treatment

NCT07339748 2026-01-15

A Clinical Study of ZL-85FA Tablets

51 enrolled

Advanced Solid Tumor

NCT07326488 2026-01-08

A Study of MHB009C in Patients With Advanced Solid Tumors

200 enrolled

Advanced Malignant Solid Tumor

NCT07327294 2026-01-08

A Phase I/II Study to Evaluate XNW34017 in Patients With Advanced or Metastatic Solid Tumor

150 enrolled

Advanced Solid Tumors

NCT07256756 2025-12-23

A Study of GC203 TIL in Advanced Solid Tumors (NF)

8 enrolled

Solid Tumors, Adult

NCT07298772 2025-12-23

A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid Tumors

198 enrolled

Advanced Solid Tumor

NCT07282873 2025-12-22

Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors

Other solid neoplasmThoracic

219 enrolled

Mesothelioma, Malignant

NCT07275853 2025-12-10

Personalized KXV01 Lentinvivo (TCR) Injection as the Therapy for Advanced Solid Tumors

Advanced Solid Tumors

NCT07272590 2025-12-09

Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors

290 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Metastatic Solid Tumors

NCT07266311 2025-12-05

CAR-T for Claudin18.2 Positive Solid Tumors

18 enrolled

Claudin18.2 Positive Advanced Solid Tumors

NCT07262164 2025-12-03

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With Solid Tumors

Advanced Malignant Solid Tumor

NCT07258121 2025-12-02

Study of ZGGS34 in Participants With Advanced Solid Tumors

400 enrolled

Solid Tumor

NCT07229612 2025-11-17

A Phase I/II Clinical Study of SHR-4298 Injection in Patients With Malignant Solid Tumors

200 enrolled

Malignant Solid Tumors

NCT07222969 2025-10-30

A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors

146 enrolled

Advanced Solid Tumors

NCT06933524 2025-10-01

ATB-320-001A

24 enrolled

Solid Tumors

NCT07190833 2025-09-24

A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea)

27 enrolled

Treatment-Refractory Solid Tumors

NCT07157956 2025-09-05

CVL006-T1002

318 enrolled

Advanced Solid Tumor

NCT07142837 2025-08-27

Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid Tumors

153 enrolled

Advanced Solid Tumor

NCT07136142 2025-08-22

A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors

150 enrolled

Malignant Solid Tumor

NCT07118709 2025-08-12

A Study of KC1086 in Patients With Advanced Solid Tumors

66 enrolled